Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#11 / 41 Total
DYAI - Dyadic International Inc., DE - Stock Price Chart
TickerDYAI [NASD]
CompanyDyadic International Inc., DE
CountryUSA
IndustryBiotechnology
Market Cap47.54MEPS (ttm)-0.24
P/E-EPS this Y32.35%
Forward P/E-EPS next Y-10.87%
PEG-EPS past 5Y-37.43%
P/S16.06EPS next 5Y-
P/B6.21EPS Q/Q12.09%
Dividend-Sales Q/Q-54.86%
Insider Own30.19%Inst Own15.66%
Insider Trans0.00%Inst Trans-2.44%
Short Float0.92%EarningsMar 28/a
Analyst Recom1.00Target Price7.50
Avg Volume21.97K52W Range1.19 - 2.40
Dyadic International, Inc. engages in developing a gene expression platform for producing commercial quantities of industrial enzymes and other proteins. It focuses on further improving and applying its proprietary C1 technology, which is used in the discovery, development, and manufacture of biologic medicines and vaccines. The company was founded by Mark A. Emalfarb in 1979 and is headquartered in Jupiter, FL.
EP - Empire Petroleum Corporation - Stock Price Chart
TickerEP [AMEX, RUT]
CompanyEmpire Petroleum Corporation
CountryUSA
IndustryOil & Gas E&P
Market Cap129.36MEPS (ttm)-0.45
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S3.31EPS next 5Y-
P/B6.14EPS Q/Q-1443.33%
Dividend-Sales Q/Q-29.95%
Insider Own28.31%Inst Own38.54%
Insider Trans21.00%Inst Trans49.27%
Short Float4.48%EarningsMar 28/a
Analyst Recom-Target Price-
Avg Volume46.68K52W Range4.61 - 13.25
Empire Petroleum Corp. engages in the exploration and development of oil and natural gas. The company possesses long-life, low operational cost, mature, producing assets with slow decline profiles in the Permian Basin, Bakken region and central Gulf Coast region, in the states of New Mexico, North Dakota, Montana, Louisiana, and Texas. Empire focuses on economical well rehabilitation, stimulation, field maintenance and management to generate low-risk cash flows that provides stability and growth for shareholders. The company was founded in August 1983 and is headquartered in Tulsa, OK.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Marchive Benjamin J. IIDirectorDec 29 '23Buy10.982,00021,95149,000Jan 02 06:04 PM
Energy Evolution Master Fund, 10% OwnerNov 29 '23Buy8.001,256,83210,054,6566,790,469Dec 01 04:44 PM
Mulacek Phil EDirectorMay 31 '23Buy8.9920,377183,1892,497,871Jun 01 06:12 PM
Vann J KevinDirectorMay 31 '23Buy8.963,11527,9103,115Jun 01 07:13 PM
Matschke Mason H.DirectorMay 31 '23Buy9.167006,412393,346Jun 01 06:13 PM
FORA - Forian Inc. - Stock Price Chart
TickerFORA [NASD]
CompanyForian Inc.
CountryUSA
IndustryHealth Information Services
Market Cap105.33MEPS (ttm)-0.18
P/E-EPS this Y98.15%
Forward P/E136.00EPS next Y266.67%
PEG-EPS past 5Y-
P/S4.58EPS next 5Y-
P/B4.14EPS Q/Q177.47%
Dividend-Sales Q/Q-25.47%
Insider Own53.41%Inst Own13.37%
Insider Trans0.01%Inst Trans-5.08%
Short Float1.14%EarningsMar 28/a
Analyst Recom1.00Target Price5.00
Avg Volume28.54K52W Range1.85 - 4.15
Forian, Inc. engages in the provision of healthcare information, analytics and technology services. The firm provides a suite of SaaS solution, as well as cannabis dispensaries. The company was founded by Max C. Wygod and Adam Dublin on October 15, 2020 and is headquartered in Newtown, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
WYGOD MARTIN JDirectorOct 04 '23Buy2.381,7004,04662,783Oct 06 04:47 PM
WYGOD MARTIN JDirectorMay 31 '23Buy2.404,78911,49461,083Jun 01 07:47 PM
WYGOD MARTIN JDirectorMay 30 '23Buy2.394,56510,91056,294Jun 01 07:47 PM
WYGOD MARTIN JDirectorMay 25 '23Buy2.343,0007,02051,729May 25 05:51 PM
WYGOD MARTIN JDirectorMay 24 '23Buy2.351,3273,11848,729May 25 05:51 PM
HSDT - Helius Medical Technologies Inc - Stock Price Chart
TickerHSDT [NASD]
CompanyHelius Medical Technologies Inc
CountryUSA
IndustryMedical Devices
Market Cap5.03MEPS (ttm)-21.49
P/E-EPS this Y72.59%
Forward P/E-EPS next Y35.48%
PEG-EPS past 5Y54.36%
P/S6.37EPS next 5Y-
P/B1.29EPS Q/Q9.01%
Dividend-Sales Q/Q-27.04%
Insider Own4.62%Inst Own7.83%
Insider Trans28.05%Inst Trans-
Short Float13.15%EarningsMar 28/a
Analyst Recom1.00Target Price17.13
Avg Volume310.64K52W Range4.29 - 14.44
Helius Medical Technologies, Inc. is a neurotech company in the medical device industry that focuses on neurological wellness. The firm develops, licenses and acquires non-invasive platform technologies that amplify the brain's ability to heal itself and reduce symptoms of neurological disease or trauma. It engages in the development of the investigational portable neuromodulation stimulator, that delivers neurostimulation via the tongue which has been shown in clinical studies to enhance the effectiveness of physical exercises in people with neurological symptoms from disease or trauma such as mild-to-moderate traumatic brain injury. The company was founded in 2014 and is headquartered in Newtown, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ANDREEFF DANEPresident and CEODec 14 '23Buy8.105,00040,47516,512Dec 15 07:00 AM
ANDREEFF DANEPresident and CEODec 01 '23Buy6.452,00612,93513,685Dec 04 08:30 AM
ANDREEFF DANEPresident and CEONov 30 '23Buy6.372,00012,74112,551Dec 04 08:30 AM
ANDREEFF DANEPresident and CEOAug 30 '23Buy7.645,00038,21211,420Aug 30 08:42 PM
ANDREEFF DANEPresident and CEOAug 28 '23Buy6.375,07832,3398,774Aug 30 08:42 PM
INLX - Intellinetics Inc - Stock Price Chart
TickerINLX [AMEX]
CompanyIntellinetics Inc
CountryUSA
IndustrySoftware - Application
Market Cap35.12MEPS (ttm)0.15
P/E55.93EPS this Y1400.00%
Forward P/E28.77EPS next Y100.00%
PEG-EPS past 5Y-
P/S2.10EPS next 5Y-
P/B3.75EPS Q/Q3.02%
Dividend-Sales Q/Q10.07%
Insider Own37.20%Inst Own0.75%
Insider Trans0.00%Inst Trans-
Short Float0.70%EarningsMar 28/a
Analyst Recom1.00Target Price8.75
Avg Volume21.07K52W Range2.92 - 10.99
Intellinetics, Inc. is a holding company, which engages in the provision of document services and software solutions to private and public sectors. It operates through the Document Management and Document Conversion segments. The Document Management segment allows customers to capture and manage all documents across operations. The Document Conversion segment assists clients as a part of overall document strategy to convert documents from one medium to another, predominantly paper to digital, including migration to software solutions. The company was founded by A. Michael Chretien, Matthew L. Chretien, and Thomas D. Moss on October 3, 1997 and is headquartered in Columbus, OH.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
TAGLICH ROBERT10% OwnerJun 13 '23Buy3.391,0003,390453,149Jun 15 05:30 PM
INMB - INmune Bio Inc - Stock Price Chart
TickerINMB [NASD]
CompanyINmune Bio Inc
CountryUSA
IndustryBiotechnology
Market Cap207.41MEPS (ttm)-1.53
P/E-EPS this Y-8.55%
Forward P/E-EPS next Y-41.41%
PEG-EPS past 5Y-83.05%
P/S942.77EPS next 5Y-
P/B4.62EPS Q/Q-10.45%
Dividend-Sales Q/Q-56.12%
Insider Own34.90%Inst Own12.80%
Insider Trans0.11%Inst Trans-4.84%
Short Float12.31%EarningsMar 28/a
Analyst Recom1.33Target Price19.67
Avg Volume78.18K52W Range5.87 - 14.74
INmune Bio, Inc. Is a clinical stage biotechnology company, which engages in developing new immunotherapies that reprograms the immune system to fight cancer and Alzheimer's disease. Its products include pipeline, INKMUNE-Cancer, INB03-Cancer, XPRO1595-Alzheimer and TRD, and LIVNate. The company was founded by Mark Lowdell in September 2015 and is headquartered in Boca Raton, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Juda ScottDirectorNov 10 '23Buy6.957,00048,65037,000Nov 13 11:31 AM
Schroeder Timothy jDirectorJul 12 '23Sale11.0110,000110,08582,187Jul 14 04:05 PM
KOD - Kodiak Sciences Inc - Stock Price Chart
TickerKOD [NASD, RUT]
CompanyKodiak Sciences Inc
CountryUSA
IndustryBiotechnology
Market Cap325.84MEPS (ttm)-5.18
P/E-EPS this Y60.78%
Forward P/E-EPS next Y47.52%
PEG-EPS past 5Y-53.05%
P/S-EPS next 5Y12.40%
P/B1.08EPS Q/Q35.29%
Dividend-Sales Q/Q-
Insider Own7.36%Inst Own76.91%
Insider Trans0.00%Inst Trans2.83%
Short Float4.16%EarningsMar 28/a
Analyst Recom3.00Target Price2.83
Avg Volume825.07K52W Range1.37 - 9.80
Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BORGESON JOHN A.See RemarksJun 16 '23Sale9.232,74925,373178,077Jun 16 08:25 PM
EHRLICH JASONSee RemarksJun 16 '23Sale9.232,25820,84161,924Jun 16 08:27 PM
BORGESON JOHN A.See RemarksJun 14 '23Sale9.421,44813,640175,332Jun 16 08:25 PM
EHRLICH JASONSee RemarksJun 14 '23Sale9.421,13210,66358,688Jun 16 08:27 PM
LFLY - Leafly Holdings Inc - Stock Price Chart
TickerLFLY [NASD]
CompanyLeafly Holdings Inc
CountryUSA
IndustryPharmaceutical Retailers
Market Cap6.80MEPS (ttm)-7.95
P/E-EPS this Y-277.31%
Forward P/E-EPS next Y-27.55%
PEG-EPS past 5Y-
P/S0.15EPS next 5Y-
P/B-EPS Q/Q-115.37%
Dividend-Sales Q/Q-10.17%
Insider Own30.15%Inst Own10.15%
Insider Trans-0.18%Inst Trans-36.86%
Short Float2.35%EarningsMar 28/a
Analyst Recom2.33Target Price7.00
Avg Volume33.10K52W Range2.06 - 16.00
Leafly Holdings, Inc. operates as an online platform to buy and learn about cannabis products. The firm's Leafly database provides information on strains and contains cannabis articles and resources to education consumers. Its customer acquisition tool connects consumers to cannabis brands and licensed retailers. Leafly offers cannabis retailers and brands subscription-based marketplace listings that provide information, reviews, menus, and ordering and delivery options through legal retailers. The company was founded in 2010 and is headquartered in Seattle, WA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Miyashita YokoCEOOct 26 '23Sale6.976714,68028,680Oct 30 04:35 PM
Krishnaswamy SureshCFOOct 26 '23Sale6.974893,41019,963Oct 30 04:37 PM
Miyashita YokoChief Executive OfficerAug 23 '23Sale0.329,3612,956577,582Aug 24 04:34 PM
Krishnaswamy SureshChief Financial OfficerAug 23 '23Sale0.326,2411,971389,036Aug 24 04:33 PM
Miyashita YokoChief Executive OfficerJul 25 '23Sale0.304,0321,210586,943Jul 27 04:40 PM
NAAS - Naas Technology Inc ADR - Stock Price Chart
TickerNAAS [NASD]
CompanyNaas Technology Inc ADR
CountryChina
IndustrySpecialty Retail
Market Cap105.59MEPS (ttm)-0.59
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-40.47%
P/S2.64EPS next 5Y24.57%
P/B12.41EPS Q/Q-202.42%
Dividend-Sales Q/Q501.62%
Insider Own0.95%Inst Own12.68%
Insider Trans0.00%Inst Trans-4.92%
Short Float2.26%EarningsMar 28/a
Analyst Recom1.00Target Price4.50
Avg Volume1.29M52W Range1.07 - 12.78
NaaS Technology, Inc. engages in the provision of electric vehicle charging services. The firm maintains an EV charging network in China through its charging network for third-party charging station operators, and the number of public DCFCs (direct current fast charger with 30kW power output or more) connected to its network. The company was founded by Zhen Dai and Yang Wang on July 16, 2013 and is headquartered in Beijing, China.
NDRA - ENDRA Life Sciences Inc - Stock Price Chart
TickerNDRA [NASD]
CompanyENDRA Life Sciences Inc
CountryUSA
IndustryDiagnostics & Research
Market Cap9.11MEPS (ttm)-2.80
P/E-EPS this Y59.43%
Forward P/E-EPS next Y23.78%
PEG-EPS past 5Y34.91%
P/S-EPS next 5Y-
P/B1.34EPS Q/Q62.95%
Dividend-Sales Q/Q-
Insider Own1.41%Inst Own1.19%
Insider Trans0.00%Inst Trans-7.66%
Short Float0.45%EarningsMar 28/a
Analyst Recom1.00Target Price11.00
Avg Volume132.17K52W Range0.80 - 2.91
ENDRA Life Sciences, Inc. develops medical imaging technology. It operates Thermo-Acoustic Enhanced UltraSound platform to enable clinicians to visualize human tissue composition, function and temperature. The company was founded on July 18, 2007 and is headquartered in Ann Arbor, MI.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Thornton Michael MilosChief Technology OfficerMay 18 '23Buy1.6515,00024,75034,139May 22 07:30 AM
DIGIANDOMENICO ANTHONYDirectorMay 02 '23Buy1.2083,333100,000102,434May 03 04:07 PM
12345